Future Trends While some companies may pull back coverage due to rising costs, others are investing in robust clinical management and holistic employee health programs, seeking long-term return on investment through improved health outcomes (WorldatWork, IFEBP)
These ads target already thin or healthy-weight individuals with promises of rapid weight loss, suggesting that smaller is always better, trivializing the use of medication, and belittling healthy behaviors like nutrition and exercise
The Future of GLP-1 Medications in Weight Management Innovations in Delivery Methods As technology advances, new delivery methods for GLP-1 medications are emerging, enhancing patient convenience and compliance
Thermally processed oil exaggerates colonic inflammation and colitis-associated colon tumorigenesis in mice
Exenatide extended-release (Bydureon) is administered as 2 mg once weekly without dose titration